German patient Inge W. had been afflicted with a hip malformation since her birth. Due to an extensive number of intense surgeries and revisions throughout her life, there was very little bone left in her pelvic region, leaving a large hole in the bone and making it very difficult to attach a standard hip implant. As her condition grew worse, it seemed that Inge had no other choice but to be confined to a wheelchair for the rest of her life. Fortunately, she was able to walk again with the help of a patient-specific 3D-printed hip implant.
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.
One of the biggest problems with brain cancer treatment is that only a limited amount of chemotherapy drugs make it through. See, our brain’s blood vessels are tightly lined with cells to keep out toxins […]
Republican Donald Trump’s shocking victory Tuesday will force a major shift in the healthcare industry’s thinking about its future. Combined with the GOP’s retention of control of the Senate and the House, a Trump presidency […]
New York Times – Many of the procedures people undergo to counter chronic knee pain in the hopes of avoiding a knee replacement have limited or no evidence to support them. Some enrich the pockets of medical practitioners while rarely benefiting patients for more than a few months. […]